Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Keith Tapper from Pivotal Research issued a price target of $14.00 for TSHA on 2026-06-23 13:16:57.The adjusted price target was set to $14.00.At the time of the announcement,
June 23, 2026 TSHA 5.28%
from Jefferies issued a price target of $8.00 for VSTM on 2026-06-23 12:34:54.The adjusted price target was set to $8.00.At the time of the announcement, VSTM was...
June 23, 2026 VSTM 0.24%
from H.C. Wainwright issued a price target of $12.00 for MCRB on 2026-06-23 10:04:10.The adjusted price target was set to $12.00.At the time of the announcement, MCRB...
June 23, 2026 MCRB 6.72%
Raghuram Selvaraju from H.C. Wainwright issued a price target of $3.00 for CGTX on 2026-06-22 11:06:00.The adjusted price target was set to $3.00.At the time of the announcement,
June 22, 2026 CGTX -3.57%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ORGNW Origin Materials Inc Warr | 0.00
50.00% | ||||||||||||||||||
| AHT-PF Ashford Hospitality Trust | 5.84
39.21% | ||||||||||||||||||
| PRPH ProPhase Labs, Inc. | 0.11
34.50% | ||||||||||||||||||
| ARQQ Arqit Quantum Inc. | 27.78
29.69% | ||||||||||||||||||
| GALT Galectin Therapeutics Inc | 3.57
27.55% | ||||||||||||||||||
| AHT-PD Ashford Hospitality Trust | 4.76
15.11% | ||||||||||||||||||
| RVPH Reviva Pharmaceuticals Ho | 0.70
14.30% | ||||||||||||||||||
| AHT-PI Ashford Hospitality Trust | 4.59
13.38% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -5.48%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -7.15%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 3.21%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.23%